(2026). Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies. eLife.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Patient-specific Midbrain Organoids with CRISPR Correction Recapitulate Neuronopathic Gaucher Disease Phenotypes and Enable Evaluation of Novel Therapies."
ELife 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Patient-specific Midbrain Organoids with CRISPR Correction Recapitulate Neuronopathic Gaucher Disease Phenotypes and Enable Evaluation of Novel Therapies."
ELife, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.